Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


March 31, 2015 8:19 AM ET

Pharmaceuticals

Company Overview of Emmaus Life Sciences, Inc.

Executive Profile

Yutaka Niihara M.D., M.P.H

Chief Executive Officer, President and Director, Emmaus Life Sciences, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
54$1,833,035
As of Fiscal Year 2013

Background

Dr. Yutaka Niihara, M.D., M.P.H has been Chief Executive Officer and President of Emmaus Life Sciences, Inc. since May 5, 2011. Dr. Niihara is a Clinical Professor of Medicine, Division of Medical Oncology/Hemotology at UCLA School of Medicine. Dr. Niihara was the Principal inventor of the patented L-glutamine therapy. Dr. Niihara has been involved in patient care and research for sickle cell disease during most of his career. He served as Chairman of the Board of Emmaus ...

Corporate Headquarters

20725 South Western Avenue
Torrance, California 90501

United States

Phone: 310-214-0065
Fax: --

Board Members Memberships

2011-Present
Chief Executive Officer, President and Director

Education

BA 1982
Loma Linda University
MD 1986
Loma Linda University School of Medicine

Other Affiliations

Annual Compensation

Salary$250,000
Total Annual Compensation$250,000

Stocks Options

Exercisable Options$83,333
Unexercisable Options$666,667
Total Number of Options$750,000

Total Compensation

Total Annual Cash Compensation$250,000
Total Short Term Compensation$250,000
Total Calculated Compensation$1,833,035
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Emmaus Life Sciences, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.